APO Research, Inc.

APO RESEARCH · REPORT

Radiation Oncology Devices

Selected research

Market Outlook & Growth Opportunities

Global Radiation Oncology Devices Market Outlook and Growth Opportunities 2026

Market perspective

The global Radiation Oncology Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Radiation Oncology Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radiation Oncology Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiation Oncology Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Radiation Oncology Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Radiation Oncology Devices market include ZEISS, Viewray Technologies, Inc, Theragenics, Siemens Healthineers AG, Sensus Healthcare, Inc, P-cure, Panacea Medical Technologies Pvt. Ltd, Optivus Proton Therapy and Mevion Medical Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Radiation Oncology Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radiation Oncology Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiation Oncology Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiation Oncology Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Radiation Oncology Devices Segment by Company

ZEISS

Viewray Technologies, Inc

Theragenics

Siemens Healthineers AG

Sensus Healthcare, Inc

P-cure

Panacea Medical Technologies Pvt. Ltd

Optivus Proton Therapy

Mevion Medical Systems

IsoRay

Ion Beam Applications

Intraop Medical

GT Medical Technologies, Inc

Elekta AB

Eckert & Ziegler Bebig

C.R. Bard

Accuray Incorporated

Radiation Oncology Devices Segment by Type

External Beam Therapy Devices

Internal Beam Therapy Devices

Radiation Oncology Devices Segment by Application

Breast Cancer

Prostate Cancer

Cervical Cancer

Others

Radiation Oncology Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radiation Oncology Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Radiation Oncology Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radiation Oncology Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Radiation Oncology Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiation Oncology Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiation Oncology Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiation Oncology Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radiation Oncology Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiation Oncology Devices industry.

Chapter 3: Detailed analysis of Radiation Oncology Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Radiation Oncology Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Radiation Oncology Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radiation Oncology Devices Industry Trends Table 2. Radiation Oncology Devices Industry Drivers Table 3. Radiation Oncology Devices Industry Opportunities and Challenges Table 4. Radiation Oncology Devices Industry Restraints Table 5. Global Radiation Oncology Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radiation Oncology Devices Revenue Share by Company (2021-2026) Table 7. Global Radiation Oncology Devices Sales Volume by Company (k units) & (2021-2026) Table 8. Global Radiation Oncology Devices Sales Volume Share by Company (2021-2026) Table 9. Global Radiation Oncology Devices Average Price (USD/unit) of Company (2021-2026) Table 10. Global Radiation Oncology Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Radiation Oncology Devices Key Company Manufacturing Base & Headquarters Table 12. Global Radiation Oncology Devices Company, Product Type & Application Table 13. Global Radiation Oncology Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Radiation Oncology Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of External Beam Therapy Devices Table 18. Significant Companies of Internal Beam Therapy Devices Table 19. Global Radiation Oncology Devices Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Radiation Oncology Devices Sales Volume by Type (2021-2026) & (k units) Table 21. Global Radiation Oncology Devices Sales Volume by Type (2027-2032) & (k units) Table 22. Global Radiation Oncology Devices Sales Volume Share by Type (2021-2026) Table 23. Global Radiation Oncology Devices Sales Volume Share by Type (2027-2032) Table 24. Global Radiation Oncology Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Radiation Oncology Devices Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Radiation Oncology Devices Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Radiation Oncology Devices Sales Value Share by Type (2021-2026) Table 28. Global Radiation Oncology Devices Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Breast Cancer Table 30. Significant Companies of Prostate Cancer Table 31. Significant Companies of Cervical Cancer Table 32. Significant Companies of Others Table 33. Global Radiation Oncology Devices Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Radiation Oncology Devices Sales Volume by Application (2021-2026) & (k units) Table 35. Global Radiation Oncology Devices Sales Volume by Application (2027-2032) & (k units) Table 36. Global Radiation Oncology Devices Sales Volume Share by Application (2021-2026) Table 37. Global Radiation Oncology Devices Sales Volume Share by Application (2027-2032) Table 38. Global Radiation Oncology Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Radiation Oncology Devices Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Radiation Oncology Devices Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Radiation Oncology Devices Sales Value Share by Application (2021-2026) Table 42. Global Radiation Oncology Devices Sales Value Share by Application (2027-2032) Table 43. Global Radiation Oncology Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Radiation Oncology Devices Sales by Region (2021-2026) & (k units) Table 45. Global Radiation Oncology Devices Sales Market Share by Region (2021-2026) Table 46. Global Radiation Oncology Devices Sales by Region (2027-2032) & (k units) Table 47. Global Radiation Oncology Devices Sales Market Share by Region (2027-2032) Table 48. Global Radiation Oncology Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Radiation Oncology Devices Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Radiation Oncology Devices Sales Value Share by Region (2021-2026) Table 51. Global Radiation Oncology Devices Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Radiation Oncology Devices Sales Value Share by Region (2027-2032) Table 53. Global Radiation Oncology Devices Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Radiation Oncology Devices Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Radiation Oncology Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Radiation Oncology Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Radiation Oncology Devices Sales by Country (2021-2026) & (k units) Table 58. Global Radiation Oncology Devices Sales Market Share by Country (2021-2026) Table 59. Global Radiation Oncology Devices Sales by Country (2027-2032) & (k units) Table 60. Global Radiation Oncology Devices Sales Market Share by Country (2027-2032) Table 61. Global Radiation Oncology Devices Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Radiation Oncology Devices Sales Value Market Share by Country (2021-2026) Table 63. Global Radiation Oncology Devices Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Radiation Oncology Devices Sales Value Market Share by Country (2027-2032) Table 65. ZEISS Company Information Table 66. ZEISS Business Overview Table 67. ZEISS Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. ZEISS Radiation Oncology Devices Product Portfolio Table 69. ZEISS Recent Development Table 70. Viewray Technologies, Inc Company Information Table 71. Viewray Technologies, Inc Business Overview Table 72. Viewray Technologies, Inc Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Viewray Technologies, Inc Radiation Oncology Devices Product Portfolio Table 74. Viewray Technologies, Inc Recent Development Table 75. Theragenics Company Information Table 76. Theragenics Business Overview Table 77. Theragenics Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Theragenics Radiation Oncology Devices Product Portfolio Table 79. Theragenics Recent Development Table 80. Siemens Healthineers AG Company Information Table 81. Siemens Healthineers AG Business Overview Table 82. Siemens Healthineers AG Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Siemens Healthineers AG Radiation Oncology Devices Product Portfolio Table 84. Siemens Healthineers AG Recent Development Table 85. Sensus Healthcare, Inc Company Information Table 86. Sensus Healthcare, Inc Business Overview Table 87. Sensus Healthcare, Inc Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Sensus Healthcare, Inc Radiation Oncology Devices Product Portfolio Table 89. Sensus Healthcare, Inc Recent Development Table 90. P-cure Company Information Table 91. P-cure Business Overview Table 92. P-cure Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. P-cure Radiation Oncology Devices Product Portfolio Table 94. P-cure Recent Development Table 95. Panacea Medical Technologies Pvt. Ltd Company Information Table 96. Panacea Medical Technologies Pvt. Ltd Business Overview Table 97. Panacea Medical Technologies Pvt. Ltd Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Panacea Medical Technologies Pvt. Ltd Radiation Oncology Devices Product Portfolio Table 99. Panacea Medical Technologies Pvt. Ltd Recent Development Table 100. Optivus Proton Therapy Company Information Table 101. Optivus Proton Therapy Business Overview Table 102. Optivus Proton Therapy Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Optivus Proton Therapy Radiation Oncology Devices Product Portfolio Table 104. Optivus Proton Therapy Recent Development Table 105. Mevion Medical Systems Company Information Table 106. Mevion Medical Systems Business Overview Table 107. Mevion Medical Systems Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Mevion Medical Systems Radiation Oncology Devices Product Portfolio Table 109. Mevion Medical Systems Recent Development Table 110. IsoRay Company Information Table 111. IsoRay Business Overview Table 112. IsoRay Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. IsoRay Radiation Oncology Devices Product Portfolio Table 114. IsoRay Recent Development Table 115. Ion Beam Applications Company Information Table 116. Ion Beam Applications Business Overview Table 117. Ion Beam Applications Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Ion Beam Applications Radiation Oncology Devices Product Portfolio Table 119. Ion Beam Applications Recent Development Table 120. Intraop Medical Company Information Table 121. Intraop Medical Business Overview Table 122. Intraop Medical Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Intraop Medical Radiation Oncology Devices Product Portfolio Table 124. Intraop Medical Recent Development Table 125. GT Medical Technologies, Inc Company Information Table 126. GT Medical Technologies, Inc Business Overview Table 127. GT Medical Technologies, Inc Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. GT Medical Technologies, Inc Radiation Oncology Devices Product Portfolio Table 129. GT Medical Technologies, Inc Recent Development Table 130. Elekta AB Company Information Table 131. Elekta AB Business Overview Table 132. Elekta AB Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Elekta AB Radiation Oncology Devices Product Portfolio Table 134. Elekta AB Recent Development Table 135. Eckert & Ziegler Bebig Company Information Table 136. Eckert & Ziegler Bebig Business Overview Table 137. Eckert & Ziegler Bebig Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Eckert & Ziegler Bebig Radiation Oncology Devices Product Portfolio Table 139. Eckert & Ziegler Bebig Recent Development Table 140. C.R. Bard Company Information Table 141. C.R. Bard Business Overview Table 142. C.R. Bard Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. C.R. Bard Radiation Oncology Devices Product Portfolio Table 144. C.R. Bard Recent Development Table 145. Accuray Incorporated Company Information Table 146. Accuray Incorporated Business Overview Table 147. Accuray Incorporated Radiation Oncology Devices Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Accuray Incorporated Radiation Oncology Devices Product Portfolio Table 149. Accuray Incorporated Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Radiation Oncology Devices Distributors List Table 153. Radiation Oncology Devices Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Radiation Oncology Devices Product Image Figure 2. Global Radiation Oncology Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiation Oncology Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Radiation Oncology Devices Sales (2021-2032) & (k units) Figure 5. Global Radiation Oncology Devices Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Radiation Oncology Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. External Beam Therapy Devices Image Figure 10. Internal Beam Therapy Devices Image Figure 11. Global Radiation Oncology Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Radiation Oncology Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Radiation Oncology Devices Sales Volume Share by Type (2021-2032) Figure 14. Global Radiation Oncology Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Radiation Oncology Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Radiation Oncology Devices Sales Value Share by Type (2021-2032) Figure 17. Breast Cancer Image Figure 18. Prostate Cancer Image Figure 19. Cervical Cancer Image Figure 20. Others Image Figure 21. Global Radiation Oncology Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Radiation Oncology Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Radiation Oncology Devices Sales Volume Share by Application (2021-2032) Figure 24. Global Radiation Oncology Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Radiation Oncology Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Radiation Oncology Devices Sales Value Share by Application (2021-2032) Figure 27. Global Radiation Oncology Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Radiation Oncology Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Radiation Oncology Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Radiation Oncology Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Radiation Oncology Devices Sales Value (2021-2032) & (US$ Million) Figure 32. North America Radiation Oncology Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Radiation Oncology Devices Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Radiation Oncology Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Radiation Oncology Devices Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Radiation Oncology Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Radiation Oncology Devices Sales Value (2021-2032) & (US$ Million) Figure 38. South America Radiation Oncology Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Radiation Oncology Devices Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Radiation Oncology Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Radiation Oncology Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Radiation Oncology Devices Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Radiation Oncology Devices Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • External Beam Therapy Devices
  • Internal Beam Therapy Devices
Applications
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Others
Companies covered
  • ZEISS
  • Viewray Technologies, Inc
  • Theragenics
  • Siemens Healthineers AG
  • Sensus Healthcare, Inc
  • P-cure
  • Panacea Medical Technologies Pvt. Ltd
  • Optivus Proton Therapy
  • Mevion Medical Systems
  • IsoRay
  • Ion Beam Applications
  • Intraop Medical
  • GT Medical Technologies, Inc
  • Elekta AB
  • Eckert & Ziegler Bebig
  • C.R. Bard
  • Accuray Incorporated

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiation Oncology Devices Sales Value (2021-2032)
  4. 1.2.2 Global Radiation Oncology Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Radiation Oncology Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Radiation Oncology Devices Market Dynamics
  1. 2.1 Radiation Oncology Devices Industry Trends
  2. 2.2 Radiation Oncology Devices Industry Drivers
  3. 2.3 Radiation Oncology Devices Industry Opportunities and Challenges
  4. 2.4 Radiation Oncology Devices Industry Restraints
3 Radiation Oncology Devices Market by Company
  1. 3.1 Global Radiation Oncology Devices Company Revenue Ranking in 2025
  2. 3.2 Global Radiation Oncology Devices Revenue by Company (2021-2026)
  3. 3.3 Global Radiation Oncology Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Radiation Oncology Devices Average Price by Company (2021-2026)
  5. 3.5 Global Radiation Oncology Devices Company Ranking (2024-2026)
  6. 3.6 Global Radiation Oncology Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Radiation Oncology Devices Company Product Type and Application
  8. 3.8 Global Radiation Oncology Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Radiation Oncology Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Radiation Oncology Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Radiation Oncology Devices Market by Type
  1. 4.1 Radiation Oncology Devices Type Introduction
  2. 4.1.1 External Beam Therapy Devices
  3. 4.1.2 Internal Beam Therapy Devices
  4. 4.2 Global Radiation Oncology Devices Sales Volume by Type
  5. 4.2.1 Global Radiation Oncology Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Radiation Oncology Devices Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Radiation Oncology Devices Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Radiation Oncology Devices Sales Value by Type
  9. 4.3.1 Global Radiation Oncology Devices Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Radiation Oncology Devices Sales Value by Type (2021-2032)
  11. 4.3.3 Global Radiation Oncology Devices Sales Value Share by Type (2021-2032)
5 Radiation Oncology Devices Market by Application
  1. 5.1 Radiation Oncology Devices Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Cervical Cancer
  5. 5.1.4 Others
  6. 5.2 Global Radiation Oncology Devices Sales Volume by Application
  7. 5.2.1 Global Radiation Oncology Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Radiation Oncology Devices Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Radiation Oncology Devices Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Radiation Oncology Devices Sales Value by Application
  11. 5.3.1 Global Radiation Oncology Devices Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Radiation Oncology Devices Sales Value by Application (2021-2032)
  13. 5.3.3 Global Radiation Oncology Devices Sales Value Share by Application (2021-2032)
6 Radiation Oncology Devices Regional Sales and Value Analysis
  1. 6.1 Global Radiation Oncology Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiation Oncology Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Radiation Oncology Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Radiation Oncology Devices Sales by Region (2027-2032)
  5. 6.3 Global Radiation Oncology Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Radiation Oncology Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Radiation Oncology Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Radiation Oncology Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Radiation Oncology Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Radiation Oncology Devices Sales Value (2021-2032)
  12. 6.6.2 North America Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Radiation Oncology Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Radiation Oncology Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Radiation Oncology Devices Sales Value (2021-2032)
  21. 6.9.2 South America Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Radiation Oncology Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Radiation Oncology Devices Sales Value Share by Country, 2025 VS 2032
7 Radiation Oncology Devices Country-level Sales and Value Analysis
  1. 7.1 Global Radiation Oncology Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radiation Oncology Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Radiation Oncology Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Radiation Oncology Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Radiation Oncology Devices Sales by Country (2027-2032)
  6. 7.4 Global Radiation Oncology Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Radiation Oncology Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Radiation Oncology Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Radiation Oncology Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Radiation Oncology Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Radiation Oncology Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ZEISS
  2. 8.1.1 ZEISS Company Information
  3. 8.1.2 ZEISS Business Overview
  4. 8.1.3 ZEISS Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ZEISS Radiation Oncology Devices Product Portfolio
  6. 8.1.5 ZEISS Recent Developments
  7. 8.2 Viewray Technologies, Inc
  8. 8.2.1 Viewray Technologies, Inc Company Information
  9. 8.2.2 Viewray Technologies, Inc Business Overview
  10. 8.2.3 Viewray Technologies, Inc Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Viewray Technologies, Inc Radiation Oncology Devices Product Portfolio
  12. 8.2.5 Viewray Technologies, Inc Recent Developments
  13. 8.3 Theragenics
  14. 8.3.1 Theragenics Company Information
  15. 8.3.2 Theragenics Business Overview
  16. 8.3.3 Theragenics Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Theragenics Radiation Oncology Devices Product Portfolio
  18. 8.3.5 Theragenics Recent Developments
  19. 8.4 Siemens Healthineers AG
  20. 8.4.1 Siemens Healthineers AG Company Information
  21. 8.4.2 Siemens Healthineers AG Business Overview
  22. 8.4.3 Siemens Healthineers AG Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Siemens Healthineers AG Radiation Oncology Devices Product Portfolio
  24. 8.4.5 Siemens Healthineers AG Recent Developments
  25. 8.5 Sensus Healthcare, Inc
  26. 8.5.1 Sensus Healthcare, Inc Company Information
  27. 8.5.2 Sensus Healthcare, Inc Business Overview
  28. 8.5.3 Sensus Healthcare, Inc Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sensus Healthcare, Inc Radiation Oncology Devices Product Portfolio
  30. 8.5.5 Sensus Healthcare, Inc Recent Developments
  31. 8.6 P-cure
  32. 8.6.1 P-cure Company Information
  33. 8.6.2 P-cure Business Overview
  34. 8.6.3 P-cure Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 P-cure Radiation Oncology Devices Product Portfolio
  36. 8.6.5 P-cure Recent Developments
  37. 8.7 Panacea Medical Technologies Pvt. Ltd
  38. 8.7.1 Panacea Medical Technologies Pvt. Ltd Company Information
  39. 8.7.2 Panacea Medical Technologies Pvt. Ltd Business Overview
  40. 8.7.3 Panacea Medical Technologies Pvt. Ltd Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Panacea Medical Technologies Pvt. Ltd Radiation Oncology Devices Product Portfolio
  42. 8.7.5 Panacea Medical Technologies Pvt. Ltd Recent Developments
  43. 8.8 Optivus Proton Therapy
  44. 8.8.1 Optivus Proton Therapy Company Information
  45. 8.8.2 Optivus Proton Therapy Business Overview
  46. 8.8.3 Optivus Proton Therapy Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Optivus Proton Therapy Radiation Oncology Devices Product Portfolio
  48. 8.8.5 Optivus Proton Therapy Recent Developments
  49. 8.9 Mevion Medical Systems
  50. 8.9.1 Mevion Medical Systems Company Information
  51. 8.9.2 Mevion Medical Systems Business Overview
  52. 8.9.3 Mevion Medical Systems Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mevion Medical Systems Radiation Oncology Devices Product Portfolio
  54. 8.9.5 Mevion Medical Systems Recent Developments
  55. 8.10 IsoRay
  56. 8.10.1 IsoRay Company Information
  57. 8.10.2 IsoRay Business Overview
  58. 8.10.3 IsoRay Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 IsoRay Radiation Oncology Devices Product Portfolio
  60. 8.10.5 IsoRay Recent Developments
  61. 8.11 Ion Beam Applications
  62. 8.11.1 Ion Beam Applications Company Information
  63. 8.11.2 Ion Beam Applications Business Overview
  64. 8.11.3 Ion Beam Applications Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ion Beam Applications Radiation Oncology Devices Product Portfolio
  66. 8.11.5 Ion Beam Applications Recent Developments
  67. 8.12 Intraop Medical
  68. 8.12.1 Intraop Medical Company Information
  69. 8.12.2 Intraop Medical Business Overview
  70. 8.12.3 Intraop Medical Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Intraop Medical Radiation Oncology Devices Product Portfolio
  72. 8.12.5 Intraop Medical Recent Developments
  73. 8.13 GT Medical Technologies, Inc
  74. 8.13.1 GT Medical Technologies, Inc Company Information
  75. 8.13.2 GT Medical Technologies, Inc Business Overview
  76. 8.13.3 GT Medical Technologies, Inc Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 GT Medical Technologies, Inc Radiation Oncology Devices Product Portfolio
  78. 8.13.5 GT Medical Technologies, Inc Recent Developments
  79. 8.14 Elekta AB
  80. 8.14.1 Elekta AB Company Information
  81. 8.14.2 Elekta AB Business Overview
  82. 8.14.3 Elekta AB Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Elekta AB Radiation Oncology Devices Product Portfolio
  84. 8.14.5 Elekta AB Recent Developments
  85. 8.15 Eckert & Ziegler Bebig
  86. 8.15.1 Eckert & Ziegler Bebig Company Information
  87. 8.15.2 Eckert & Ziegler Bebig Business Overview
  88. 8.15.3 Eckert & Ziegler Bebig Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Eckert & Ziegler Bebig Radiation Oncology Devices Product Portfolio
  90. 8.15.5 Eckert & Ziegler Bebig Recent Developments
  91. 8.16 C.R. Bard
  92. 8.16.1 C.R. Bard Company Information
  93. 8.16.2 C.R. Bard Business Overview
  94. 8.16.3 C.R. Bard Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 C.R. Bard Radiation Oncology Devices Product Portfolio
  96. 8.16.5 C.R. Bard Recent Developments
  97. 8.17 Accuray Incorporated
  98. 8.17.1 Accuray Incorporated Company Information
  99. 8.17.2 Accuray Incorporated Business Overview
  100. 8.17.3 Accuray Incorporated Radiation Oncology Devices Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Accuray Incorporated Radiation Oncology Devices Product Portfolio
  102. 8.17.5 Accuray Incorporated Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radiation Oncology Devices Value Chain Analysis
  2. 9.1.1 Radiation Oncology Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radiation Oncology Devices Sales Mode & Process
  6. 9.2 Radiation Oncology Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radiation Oncology Devices Distributors
  9. 9.2.3 Radiation Oncology Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.